军事知识服务平台
A组链球菌疫苗与快速检测的协同防控策略
Synergistic prevention and control strategies for Group A Streptococcus vaccines and rapid detection
摘要 A组链球菌(Group A Streptococcus,GAS)是常见致病性革兰氏阳性菌,可引起多种人类感染性疾病,造成全球严重疾病负担.该文综述了GAS疫苗类型及优劣,总结快速检测技术的研究进展,为GAS感染防护策略提供理论基础.文章梳理了 GAS生物学特性及其毒力因子致病机制,并系统阐述M蛋白疫苗和非M蛋白疫苗两大研发方向,进一步探讨疫苗结构关键要素,包括抗原、佐剂及载体对免疫应答的重要性;此外,讨论了快速检测技术的作用原理及性能评估.揭示出GAS疫苗向广谱、高效与安全方向发展的趋势,快速检测技术趋于高灵敏度与操作便捷化,二者协同为遏制GAS感染提供了双重保障.
Abstract:
Group A Streptococcus(GAS),a common pathogenic Gram-positive bacterium,is recognized to cause a variety of human infectious diseases and imposes a substantial global disease burden.The article reviews the types and advantages and disadvantages of GAS vaccines and to summarize research advances in rapid detection techniques,in order to provide a novel theoretical basis for prevention strategies against GAS infections.The biological characteristics of GAS and the pathogenic mech-anisms of its virulence factors were outlined.Two major research directions for vaccine development,M protein vaccines and non-M protein vaccines,were systematically described.The critical components of vaccine structure,including antigens,adju-vants,and carriers,were further discussed for their importance in the immune response.In addition,the working principles and performance evaluations of rapid detection techniques were addressed.In summary,GAS vaccines are being developed toward broad spectrum,high efficacy,and safety,while rapid detection techniques are trending toward high sensitivity and operational convenience.The synergistic progress is expected to offer a dual guarantee for effectively curbing GAS infection.
刊 名 生物技术
年,卷(期): 2026, 36(3)
分类号: R378.12
机标分类号: R183 R511.7 S858.28
在线出版日期: 2026年8月6日